Stereoselective synthesis of (1R,2S,3R)-camphordiamine.
Busacca
C A
CA
Department of Chemical Development, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut 06877-0368, USA. cbusacca@rdg.boehringer-ingelheim.com
Campbell
S
S
Dong
Y
Y
Grossbach
D
D
Ridges
M
M
Smith
L
L
Spinelli
E
E
D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry; D002164:Camphor / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000737:chemistry; D003959:Diamines / Q000138:chemical synthesis* / Q000737:chemistry; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D013237:Stereoisomerism
D000970:Antineoplastic Agents; D003959:Diamines; C415332:camphordiamine; D002164:Camphor